204 related articles for article (PubMed ID: 28268254)
21. Outcomes for paediatric Burkitt lymphoma treated with anthracycline-based therapy in Malawi.
Stanley CC; Westmoreland KD; Heimlich BJ; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kaimila B; Kasonkanji E; Chimzimu F; Kampani C; Dhungel BM; Krysiak R; Montgomery ND; Fedoriw Y; Rosenberg NE; Liomba NG; Gopal S
Br J Haematol; 2016 Jun; 173(5):705-12. PubMed ID: 26914979
[TBL] [Abstract][Full Text] [Related]
22. Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma.
Rieken J; Bernard V; Witte HM; Peter W; Merz H; Olschewski V; Hertel L; Lehnert H; Biersack H; von Bubnoff N; Feller AC; Gebauer N
Br J Haematol; 2021 Apr; 193(1):138-149. PubMed ID: 32945554
[TBL] [Abstract][Full Text] [Related]
23. [Signification of Epstein-Barr virus detection in the cerebrospinal fluid of a patient with human immunodeficiency virus related Burkitt lymphoma].
Jennane S; Mahtat el M; Konopacki J; Foissaud V; Souleau B; Malfuson JV; De Revel T
Ann Biol Clin (Paris); 2013; 71(3):341-4. PubMed ID: 23747673
[TBL] [Abstract][Full Text] [Related]
24. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.
Hochberg D; Middeldorp JM; Catalina M; Sullivan JL; Luzuriaga K; Thorley-Lawson DA
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):239-44. PubMed ID: 14688409
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma.
Qin JQ; Yin H; Wu JZ; Chen RZ; Xia Y; Wang L; Zhu HY; Fan L; Li JY; Liang JH; Xu W
Leuk Res; 2021 Aug; 107():106607. PubMed ID: 33957372
[TBL] [Abstract][Full Text] [Related]
26. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
[TBL] [Abstract][Full Text] [Related]
27. EBV Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria.
Habeeb R; Al Hafar L; Monem F
J Infect Dev Ctries; 2021 Dec; 15(12):1917-1922. PubMed ID: 35044951
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder.
Picarsic J; Jaffe R; Mazariegos G; Webber SA; Ellis D; Green MD; Reyes-Múgica M
Cancer; 2011 Oct; 117(19):4540-50. PubMed ID: 21446044
[TBL] [Abstract][Full Text] [Related]
29. Burkitt's Lymphoma.
Rochford R; Moormann AM
Curr Top Microbiol Immunol; 2015; 390(Pt 1):267-85. PubMed ID: 26424650
[TBL] [Abstract][Full Text] [Related]
30. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.
Barros MH; Vera-Lozada G; Soares FA; Niedobitek G; Hassan R
Int J Cancer; 2012 Sep; 131(5):1142-52. PubMed ID: 22025264
[TBL] [Abstract][Full Text] [Related]
31. Seroepidemiological analysis and literature review of the prevalence of Epstein-Barr virus and herpesvirus infections in pediatric cases with non-Hodgkin lymphoma in Central Europe.
Vaillant V; Reiter A; Zimmermann M; Wagner HJ
Pediatr Blood Cancer; 2019 Jul; 66(7):e27752. PubMed ID: 30977593
[TBL] [Abstract][Full Text] [Related]
32. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection.
Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934
[TBL] [Abstract][Full Text] [Related]
33. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma.
Jimenez O; Colli S; Garcia Lombardi M; Preciado MV; De Matteo E; Chabay P
Cancer Immunol Immunother; 2021 Jun; 70(6):1519-1526. PubMed ID: 33184699
[TBL] [Abstract][Full Text] [Related]
35. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
36. An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma.
Murray PG; Young LS
Blood; 2019 Aug; 134(7):591-596. PubMed ID: 31186275
[TBL] [Abstract][Full Text] [Related]
37. Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda.
Ravell J; Otim I; Nabalende H; Legason ID; Reynolds SJ; Ogwang MD; Ndugwa CM; Marshall V; Whitby D; Goedert JJ; Engels EA; Bhatia K; Lenardo MJ; Mbulaiteye SM
Cancer Epidemiol; 2018 Feb; 52():70-74. PubMed ID: 29248801
[TBL] [Abstract][Full Text] [Related]
38. Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.
Shen T; Tang LQ; Luo DH; Chen QY; Li PJ; Mai DM; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mo HY; Mai HQ
PLoS One; 2015; 10(4):e0122756. PubMed ID: 25853677
[TBL] [Abstract][Full Text] [Related]
39. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
[TBL] [Abstract][Full Text] [Related]
40. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
